An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets
Authors:
- Sıdıka ErtürkSESıdıka Ertürk
- Esra Sevinç AktaşEAEsra Sevinç Aktaş
- Lale ErsoyLELale Ersoy
- Samiye FıçıcıoğluSFSamiye Fıçıcıoğlu
- 1 December 2003
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 33 (5) , 1017-1023
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Determination of cholesterol-lowering statin drugs in aqueous samples using liquid chromatography–electrospray ionization tandem mass spectrometryJournal of Chromatography A, 2003
- Determination of pharmaceuticals in aqueous samples using positive and negative voltage switching microbore liquid chromatography/electrospray ionization tandem mass spectrometryJournal of Mass Spectrometry, 2002
- Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high-performance liquid chromatography with electrospray tandem mass spectrometryRapid Communications in Mass Spectrometry, 1999
- AtorvastatinDrugs, 1997
- Tolerance and Pharmacokinetics of Single‐Dose Atorvastatin, a Potent Inhibitor of HMG‐CoA Reductase, in Healthy SubjectsThe Journal of Clinical Pharmacology, 1996
- Selection of high-performance liquid chromatographic methods in pharmaceutical analysisJournal of Chromatography A, 1988